Clinical Trials Browser

Phase NA × perfluorobutane × Gastrointestinal × Clear all

NCT05068076 2021-12-21

Role of Perfluorobutane in Lesion Detection, Targeting and Response Assessment for Ablation of HCC

Phase NA Completed

Gastrointestinal

Carcinoma, Hepatocellular